267 related articles for article (PubMed ID: 8205552)
1. A dominated and resistant subpopulation causes regrowth after response to 1,3-bis(2-chloroethyl)-1-nitrosourea treatment of a heterogeneous small cell lung cancer xenograft in nude mice.
Aabo K; Roed H; Vindeløv LL; Spang-Thomsen M
Cancer Res; 1994 Jun; 54(12):3295-9. PubMed ID: 8205552
[TBL] [Abstract][Full Text] [Related]
2. Low-dose chemotherapy delays relapse of a dominated and resistant sub-population in a heterogeneous human SCLC xenograft in nude mice.
Aabo K; Vindeløv LL; Christensen IJ; Spang-Thomsen M
Int J Cancer; 1994 Nov; 59(3):394-9. PubMed ID: 7927948
[TBL] [Abstract][Full Text] [Related]
3. Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts.
Dolan ME; Fleig MJ; Feuerstein BG; Basu HS; Luk GD; Casero RA; Marton LJ
Cancer Res; 1994 Sep; 54(17):4698-702. PubMed ID: 8062267
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitivity of human small cell carcinoma of the lung detected by flow cytometric DNA analysis of drug-induced cell cycle perturbations in vitro.
Engelholm SA; Spang-Thomsen M; Vindeløv LL; Brünner NA
Cytometry; 1986 May; 7(3):243-50. PubMed ID: 3011370
[TBL] [Abstract][Full Text] [Related]
5. Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine.
Luk GD; Abeloff MD; McCann PP; Sjoerdsma A; Baylin SB
Cancer Res; 1986 Apr; 46(4 Pt 1):1849-53. PubMed ID: 3004708
[TBL] [Abstract][Full Text] [Related]
6. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
7. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
Slagel DE; Feola J; Houchens DP; Ovejera AA
Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts.
Arvelo F; Poupon MF; Le Chevalier T
Anticancer Res; 1994; 14(5A):1893-901. PubMed ID: 7847823
[TBL] [Abstract][Full Text] [Related]
9. Effect of serotonin and nicotine on the growth of a human small cell lung cancer xenograft.
Pratesi G; Cervi S; Balsari A; Bondiolotti G; Vicentini LM
Anticancer Res; 1996; 16(6B):3615-9. PubMed ID: 9042230
[TBL] [Abstract][Full Text] [Related]
10. Differential repair of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea-induced DNA damage in two human colon tumor cell lines.
Erickson LC; Osieka R; Kohn KW
Cancer Res; 1978 Mar; 38(3):802-8. PubMed ID: 626984
[TBL] [Abstract][Full Text] [Related]
11. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
12. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
13. Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU.
Schold SC; Kokkinakis DM; Rudy JL; Moschel RC; Pegg AE
Cancer Res; 1996 May; 56(9):2076-81. PubMed ID: 8616853
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice.
Luk GD; Abeloff MD; Griffin CA; Baylin SB
Cancer Res; 1983 Sep; 43(9):4239-43. PubMed ID: 6409400
[TBL] [Abstract][Full Text] [Related]
15. Contribution of glutathione transferase M3-3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small cell lung cancer cell line.
Berhane K; Hao XY; Egyházi S; Hansson J; Ringborg U; Mannervik B
Cancer Res; 1993 Sep; 53(18):4257-61. PubMed ID: 8395980
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
17. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea of the EMT6 tumor in vivo as determined by both tumor volume response and in vitro plating assay.
Twentyman PR
Cancer Res; 1978 Aug; 38(8):2395-400. PubMed ID: 667838
[TBL] [Abstract][Full Text] [Related]
19. Proto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines.
Liu C; Tsao MS
Am J Pathol; 1993 Feb; 142(2):413-23. PubMed ID: 8382008
[TBL] [Abstract][Full Text] [Related]
20. Cellular replication kinetics and persistence of sister chromatid exchange-inducing lesions in normal and lymphoma AKR cells following exposure to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Biegel JA; Conner MK; Boggs SS
Cancer Res; 1982 Jul; 42(7):2816-20. PubMed ID: 7083172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
